Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

330.83 +5.74 (+1.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,191,329
Open 327.82
Bid (Size) 330.83 (3)
Ask (Size) 333.80 (1)
Prev. Close 325.09
Today's Range 326.01 - 333.85
52wk Range 224.34 - 333.85
Shares Outstanding N/A
Dividend Yield 2.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts. 
Via Investor's Business Daily
Check Out What Whales Are Doing With AMGN
Via Benzinga

Performance

YTD
+11.24%
+11.24%
1 Month
+9.88%
+9.88%
3 Month
+23.78%
+23.78%
6 Month
+7.93%
+7.93%
1 Year
+45.32%
+45.32%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
TSLA Hit Our Target - Here’s What’s Next
Via Talk Markets
Topics Economy
Exposures Interest Rates
7 Cheap Biotech Stocks With Major Upside Potential
Via InvestorPlace
What the Options Market Tells Us About Amgen
Via Benzinga
Amgen Unusual Options Activity
Via Benzinga
Can Amgen Stock Keep Trouncing the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
Via The Motley Fool
3 Small-Cap Stocks With Explosive 2X Growth Potential
Via InvestorPlace
3 Dividend Stocks Crushing the S&P 500 With 30%+ Annual Total Returns
Via InvestorPlace
Topics Stocks
Exposures US Equities
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Via Benzinga
Topics ETFs
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
Via Talk Markets
Smart Money Is Betting Big In AMGN Options
Via Benzinga
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
Via Investor's Business Daily
Amgen, Inc. Dividend Stock Analysis
Via Talk Markets
The 3 Best Healthcare Stocks to Buy in July 2024
Via InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
Via The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
1 Dividend Growth Stock to Buy and Hold for 10 Years
Via The Motley Fool
10 Blue-Chip Dividend Growth Stocks With 3% Yields And Safe Dividends
Via Talk Markets
These Are The Best Dow Jones Stocks Of 2024 Thus Far
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Tech Is Consolidating And The Market’s Seeking New Leadership
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.